🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
ß blocker and digoxin effect on left atrium reservoir function are unknown....
Status
Unknown
Location
Fattouma Bourguiba University hospital
Start Date
2022-09-12
Trial ID
NCT05540600
Treatments Being Tested
To study the Pharmacokinetics (PK) parameters of montelukast, flurbiprofen,...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02456844
The primary objective of this trial is to investigate the relative bioavail...
Status
Completed
Location
CTC North GmbH & Co. KG, Hamburg
Start Date
2017-10-25
Trial ID
NCT03307252
Treatments Being Tested
This was a 2-part study (Part 1 and Part 2), with each part being an open-l...
Status
Completed
Location
Clinical Study Site
Start Date
2019-12-22
Trial ID
NCT04709081
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics of midazolam ...
Status
Completed
Location
Baltimore - Early Phase Clinical Unit
Start Date
2022-09-22
Trial ID
NCT05541471
This is a single-center, open-label, fixed-sequence phase I clinical study ...
Status
Recruiting
Location
Study site 01
Start Date
2025-11-17
Trial ID
NCT07128888
Treatments Being Tested
The purpose of this study is determine that Dapagliflozin has no effect on ...
Status
Completed
Location
Pra International
Start Date
2009-06
Trial ID
NCT00904176
Treatments Being Tested
THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2017-08-15
Trial ID
NCT03016819
An open label, balanced, randomized, single-dose, two-treatment, two-sequen...
Status
Completed
Location
ClinSync Clinical Research Pvt. Ltd.
Start Date
2019-03-10
Trial ID
NCT03909529
Treatments Being Tested
This trial is conducted in china. The aim of the trial is as follows: * To...
Status
Completed
Location
Peking University Third Hospital drug clinical trial Institute
Start Date
2023-10-19
Trial ID
NCT06247748